Gaziano, LiamGiambartolomei, ClaudiaPereira, Alexandre C.Gaulton, AnnaPosner, Daniel C.Swanson, Sonja A.Ho, Yuk-LamIyengar, Sudha K.Kosik, Nicole M.Vujkovic, MarijanaGagnon, David R.Bento, A. PatríciaBarrio-Hernandez, InigoRönnblom, LarsHagberg, NiklasLundtoft, ChristianLangenberg, ClaudiaPietzner, MaikValentine, DennisGustincich, StefanoTartaglia, Gian GaetanoAllara, EliasSurendran, PraveenBurgess, StephenZhao, Jing HuaPeters, James E.Prins, Bram P.Angelantonio, Emanuele DiDevineni, PoornimaShi, YunlingLynch, Kristine E.DuVall, Scott L.Garcon, HeleneThomann, Lauren O.Zhou, Jin J.Gorman, Bryan R.Huffman, Jennifer E.O’Donnell, Christopher J.Tsao, Philip S.Beckham, Jean C.Pyarajan, SaijuMuralidhar, SumitraHuang, Grant D.Ramoni, RachelBeltrao, PedroDanesh, JohnHung, Adriana M.Chang, Kyong-MiSun, Yan V.Joseph, JacobLeach, Andrew R.Edwards, Todd L.Cho, KellyGaziano, J. MichaelButterworth, Adam S.Casas, Juan P.Casas2023-08-252021-04Gaziano, Liam, Claudia Giambartolomei, Alexandre C. Pereira, Anna Gaulton, Daniel C. Posner, Sonja A. Swanson, Yuk-Lam Ho et al. "Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19." Nat Med 27, no. 4 (2021): 668-676. DOI: 10.1038/s41591-021-01310-z1078-89561546-170Xhttps://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37376907Completed on behalf of authors upon email request from Nicole Kosik on 2/17/2021en-USGeneral Biochemistry, Genetics and Molecular BiologyGeneral MedicineJournal Article2023-08-2510.1038/s41591-021-01310-z